Course Description:
Processes that provide economical, safe, and green access to chemically modified oligonucleotides is of paramount importance in the manufacturing of therapeutic drugs. So far, ten oligonucleotides have been approved by the US FDA and over hundred products are undergoing human clinical trials. To support the anticipated large-scale commercial demand of these molecules, we have developed improved synthetic methodologies following the twelve principles of green chemistry. This presentation will summarize our efforts in enabling environmentally friendly chemistry.
The live version of this recording took place on March 5, 2021 and features
a presentation by Yogesh S. Sanghvi, Ph.D.
Who should participate:
- Analytical chemists
- QA/QC analysts
- R&D scientists, managers
- Team members in CMC development projects
- Manufacturing scientists, managers
- Regulatory affairs specialists
- Contract research organizations
- Contract manufacturing organizations
Access Duration:Access to this course expires 60 days from the date of registration or until you mark the course ‘Complete’ – whichever occurs first.